E71.52

Clinical Causes: Mutations in the ABCD1 gene, located on the X chromosome Inheritance pattern is X-linked recessive, meaning males are primarily affected and females are carriers Failure to break down very long-chain fatty acids, resulting in their accumulation in tissues and blood

Key Symptoms: Progressive neurological problems such as difficulty walking, muscle weakness, and coordination issues Behavioral changes including learning difficulties, irritability, or behavioral regression Adrenal insufficiency leading to symptoms like fatigue, muscle weakness, weight loss, and low blood pressure Vision problems, including changes in sight or blindness in advanced cases Hearing difficulties or problems with speech in some individuals In childhood-onset forms, rapid progression may cause severe neurological decline within a few years

Diagnosis Path: Diagnosis of X-linked adrenoleukodystrophy involves a combination of blood tests, genetic analysis, and imaging studies. Key diagnostic steps include: - Blood tests to measure levels of very long-chain fatty acids (VLCFAs), which are elevated in individuals with X-ALD - Genetic testing to identify mutations in the ABCD1 gene - Brain MRI scans to detect white matter changes characteristic of the disease - Evaluation of adrenal function to check for adrenal insufficiency Early diagnosis is crucial for managing symptoms and planning appropriate care, although there is currently no cure for X-ALD.

Treatment Protocols: While there is no definitive cure for X-linked adrenoleukodystrophy, treatments focus on managing symptoms and slowing disease progression. Common approaches include: - Hormone replacement therapy for adrenal insufficiency, typically with corticosteroids - Bone marrow or stem cell transplants in certain cases, especially in early-stage brain involvement, to potentially halt disease progression - Symptomatic treatments such as physical therapy, occupational therapy, and speech therapy to improve quality of life - Regular neurological and endocrine evaluations to monitor disease progression - Emerging gene therapy research offers hope for future targeted treatments, but these are still under investigation Supportive care and a multidisciplinary approach are essential in managing the condition effectively.